Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Prakash, Ipshita, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, and Oluwadamilola M. Fayanju. “Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.” Breast Cancer Res Treat 186, no. 2 (April 2021): 535–50. https://doi.org/10.1007/s10549-020-06012-7.

Full Text

Tamirisa, Nina P., Yi Ren, Brittany M. Campbell, Samantha M. Thomas, Oluwadamilola M. Fayanju, Jennifer K. Plichta, Laura H. Rosenberger, et al. “Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.” Ann Surg Oncol 28, no. 4 (April 2021): 2146–54. https://doi.org/10.1245/s10434-020-09024-1.

Full Text

Fayanju, Oluwadamilola M., Yi Ren, Ilona Stashko, Steve Power, Madeline J. Thornton, P Kelly Marcom, Terry Hyslop, and E Shelley Hwang. “Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.” Cancer 127, no. 5 (March 1, 2021): 757–68. https://doi.org/10.1002/cncr.33310.

Full Text

Ladipo, O. L., Y. Ren, K. B. Caddell, A. Sampathkumar, C. A. Almond, and O. M. Fayanju. “Does treatment sequence affect outcomes in patients with metaplastic breast cancer?” American Journal of Surgery, January 1, 2021. https://doi.org/10.1016/j.amjsurg.2021.01.007.

Full Text

Fayanju, Oluwadamilola M., Scott T. Hollenbeck, and Rachel A. Greenup. “Oncologic Outcomes After Neoadjuvant Chemotherapy and Postmastectomy Breast Reconstruction.” Jama Surg 155, no. 12 (December 1, 2020): 1150–51. https://doi.org/10.1001/jamasurg.2020.4138.

Full Text

Sergesketter, Amanda R., Samantha M. Thomas, Edgardo R. Parrilla Castellar, Oluwadamilola M. Fayanju, Carolyn Menendez, E Shelley Hwang, and Jennifer K. Plichta. “Do Histopathology and Clinical Outcomes of Breast Atypia Vary by Race/Ethnicity?” J Surg Res 255 (November 2020): 205–15. https://doi.org/10.1016/j.jss.2020.05.066.

Full Text

Plichta, Jennifer K., Yi Ren, Caitlin E. Marks, Samantha M. Thomas, Rachel A. Greenup, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Susan G. R. McDuff, E Shelley Hwang, and Jeremy Force. “Surgery for Men with Breast Cancer: Do the Same Data Still Apply?” Ann Surg Oncol 27, no. 12 (November 2020): 4720–29. https://doi.org/10.1245/s10434-020-08901-z.

Full Text

Tait, Sarah D., Yi Ren, Cushanta C. Horton, Sachiko M. Oshima, Samantha M. Thomas, Sherry Wright, Awanya Caesar, et al. “Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program (NC BCCCP): A review of 90,000 women.” In Journal of Clinical Oncology, Vol. 38, 2020.

Scholars@Duke

Caddell, Keenan B., Yi Ren, Anuyuga Sampathkumar, Chandra A. Almond, Oluwatomi L. Ladipo, Colin E. Champ, Laura Horst Rosenberger, et al. “The effect of body mass index (BMI) on survival in patients with breast cancer and obesity-associated conditions.” In Journal of Clinical Oncology, Vol. 38, 2020.

Scholars@Duke

Champion, Cosette D., Samantha M. Thomas, Jennifer K. Plichta, Edgardo Parrilla Castellar, Laura H. Rosenberger, Rachel A. Greenup, Terry Hyslop, E Shelley Hwang, and Oluwadamilola M. Fayanju. “Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.” Jco Oncol Pract, October 7, 2020, OP2000381. https://doi.org/10.1200/OP.20.00381.

Full Text

Pages